pCDNA3.0_mitoNanobody Citations (1)

Originally described in: Chemogenetic Control of Nanobodies.
Farrants H, Tarnawski M, Muller TG, Otsuka S, Hiblot J, Koch B, Kueblbeck M, Krausslich HG, Ellenberg J, Johnsson K Nat Methods. 2020 Feb 17. pii: 10.1038/s41592-020-0746-7. doi: 10.1038/s41592-020-0746-7. PubMed Journal

---

Articles Citing pCDNA3.0_mitoNanobody

Articles
Blood-brain barrier-penetrative lipid nanoparticles enable systemic delivery of TRIM11 mRNA to disaggregate Tau in Alzheimer's disease models. Zou Y, Sang Y, Zheng M, Shi B. Cell Rep Med. 2026 Mar 17;7(3):102685. doi: 10.1016/j.xcrm.2026.102685. PubMed

If you have published an article using this material, please email us at to have your article added to this page.